サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1564957

高分解能融解分析の世界市場

High-Resolution Melting Analysis

出版日
ページ情報
英文 179 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
高分解能融解分析の世界市場
出版日: 2024年10月04日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

高分解能融解分析の世界市場は2030年までに4億1,920万米ドルに達する見込み

2023年に3億4,380万米ドルと推定される高分解能融解分析の世界市場は、2023年から2030年にかけてCAGR 2.9%で成長し、2030年には4億1,920万米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるその他のアプリケーションは、CAGR 1.4%を記録し、分析期間終了時には3,110万米ドルに達すると予測されます。エピジェネティクスアプリケーションセグメントの成長率は、分析期間でCAGR 1.7%と推定されます。

米国市場は9,250万米ドルと推定、中国はCAGR2.7%で成長すると予測

米国の高分解能融解分析市場は、2023年に9,250万米ドルと推定されます。世界第2位の経済大国である中国は、2023年から2030年の分析期間においてCAGR 2.7%で推移し、2030年には予測市場規模6,710万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.7%と2.3%と予測されています。欧州では、ドイツがCAGR 3.2%で成長すると予測されています。

世界の高分解能融解分析市場- 主要動向と促進要因のまとめ

高分解能融解分析（HRM）は現代の分子診断における迅速かつ正確なゲノムプロファイリングの鍵か？

高分解能融解（HRM）分析は、分子診断学と遺伝子研究に革命をもたらしていますが、なぜこの方法が現代のラボで非常に重要なのでしょうか？HRMはPCR（ポリメラーゼ連鎖反応）後の分析技術で、DNA中の一塩基多型（SNP）、突然変異、メチル化の違いなどの遺伝的変異を同定するために使用されます。二本鎖DNAが一本鎖に解離する際の正確な融解挙動をモニターすることにより、HRMはDNA配列の微妙な変化を検出するための迅速でハイスループットな方法を提供します。医療診断、遺伝子研究、エピジェネティック研究、病原体検出などに広く利用されており、手間のかかるシークエンシング法に代わる、コスト効率が高く、正確で効率的な方法を提供しています。

HRMの魅力は、最小限のセットアップとコストで詳細なゲノム情報を提供できる点にあります。HRMは高速でスケーラブルであり、自動化が可能であるため、臨床現場、がん研究、農業バイオテクノロジーなど、迅速な結果が不可欠な用途に最適です。HRMは、わずかな遺伝子変異も検出できる感度の高さから、病気の原因となる変異の同定、薬剤耐性のモニタリング、遺伝子マーカーの検証に威力を発揮します。ゲノム研究と精密医療が拡大し続ける中、HRMは分子診断学と個別化ヘルスケアの進歩において、ますます重要な役割を果たしています。

テクノロジーはどのように進歩したか高分解能融解分析

技術の進歩により、高分解能融解分析の感度、精度、効率は大幅に改善され、遺伝学的および診断学的応用において、より身近で強力なツールとなりました。主な発展の一つは、高解像度の光学系と温度制御を備えた、より精密なリアルタイムPCR装置の開発です。これらの装置は高精度でDNAの融解曲線を正確に測定することができ、DNA配列の最も微妙な違いも検出することができます。サーマルサイクラーの改良により、温度変化をより細かく制御できるようになった。これは、近縁の遺伝子変異を区別する再現性の高い高分解能の融解プロファイルを作成するのに不可欠です。

HRM用に特別に設計されたインターカレート色素のイントロダクションも、この技術の精度と性能を向上させました。DNA増幅に使用されるSYBR Greenのような従来の蛍光色素は、わずかな配列変異の検出に限界があった。LCGreenやEvaGreenのような新しい色素は、二本鎖DNAにより選択的に結合し、より安定した蛍光シグナルを生成するため、わずかな遺伝子変化に伴う融解温度シフトをより識別しやすくなります。これらの色素はHRMの感度を向上させ、ヘテロ接合変異、SNP、メチル化の違いをより明瞭に検出することを可能にします。

HRM解析用ソフトウェアの進歩により、複雑な融解プロファイルの解釈はさらに最適化されました。最新のHRMソフトウェアは、より高い精度で融解曲線を解析するように設計されており、研究者は実験データを既知の参照曲線と比較することにより、わずかな遺伝的差異を検出し定量化することができます。これらのアルゴリズムは、自動的に複数の融解曲線を同時に解析し、パターンを特定し、さらに実験中にリアルタイムでフィードバックを提供することができます。機械学習とAI主導の分析ツールの統合により、HRMは遺伝子データの微妙な差異を特定する能力が強化され、結果の信頼性が向上し、臨床と研究の両方の用途でより使いやすい技術となった。

また、マルチプレックス機能により、1回の反応で複数の遺伝子座またはサンプルを同時に分析できるようになり、HRMの有用性が向上しました。最適化されたプライマー設計と色素選択の助けにより、HRMは現在、1回のランで複数のターゲットを区別するために使用することができ、スループットの向上とコストの削減を実現しています。この進歩は、患者サンプル中の複数の突然変異や遺伝子マーカーを迅速に検出することが、病気の診断、治療反応のモニタリング、薬剤耐性病原体の同定に不可欠である臨床診断において、特に有用です。マルチプレックスHRMはまた、遺伝子スクリーニング・プログラムの効率を向上させ、特定の遺伝子変異について大規模な集団を時間的にもコスト的にも効率的な方法で分析することができます。

HRMと次世代シーケンシング（NGS）技術との統合が進むにつれ、ゲノミクス研究におけるHRMの役割も拡大しています。HRMは迅速でコスト効率に優れたスクリーニングツールですが、シーケンス前のサンプルの確認や事前スクリーニングにNGSと組み合わせて使用されることも増えています。HRMは既知の変異や変異を持つサンプルを迅速に同定できるため、全ゲノムの大規模なシーケンスの必要性を減らすことができます。このアプローチは遺伝子解析プロセスを合理化し、研究および臨床応用の両方で時間とリソースを節約します。HRMは、研究者がより詳細なシーケンスを行うための候補サンプルを迅速に特定する必要がある大規模遺伝子研究において特に有用です。

さらにHRMは、エピジェネティックな研究に不可欠なメチル化解析への応用にも改良が加えられています。DNAメチル化は遺伝子制御に重要な役割を果たしており、がんを含む様々な疾患に関与しています。メチル化感受性HRM（MS-HRM）は、融解挙動の違いを利用することで、メチル化されたDNA領域とメチル化されていないDNA領域を区別することを可能にし、エピジェネティック解析のための迅速な非シークエンスベースの手法を提供します。このため、HRMは、遺伝子発現や疾患発症におけるエピジェネティック修飾の役割、特に腫瘍学を理解する上で不可欠なツールとなっています。

なぜ高分解能融解分析が現代の分子診断学と研究に不可欠なのか？

高分解能融解分析は、疾患、薬剤耐性、遺伝性疾患を理解する鍵となる遺伝的変異を検出するための、迅速、正確、かつ費用対効果の高い方法を提供するため、現代の分子診断学および研究にとって極めて重要です。臨床診断では、嚢胞性線維症、鎌状赤血球貧血、サラセミアなどの遺伝性疾患に関連する遺伝子の変異を同定するためにHRMが使用されています。一塩基多型（SNPs）やその他のわずかな遺伝的変化を検出することができるため、病気を引き起こす突然変異について患者をスクリーニングしたり、遺伝性疾患の保因者を同定したりするのに理想的です。これは特に出生前や新生児スクリーニングにおいて重要であり、遺伝子異常の早期発見が医療介入の指針となり、患者の転帰を改善することができます。

HRMの重要性はがん診断や個別化医療にも及んでおり、BRCA1、KRAS、EGFRといったがん関連遺伝子の特定の変異を特定することは、最も効果的な治療戦略を決定する上で極めて重要です。HRMは、がんの進行や標的治療に対する患者の反応性に影響を及ぼす可能性のある既知の変異と新規の変異の両方を迅速に検出することができます。HRMは、実用的な突然変異の迅速な同定を可能にすることで、個人の腫瘍の遺伝子プロファイルに合わせた治療を行う、精密腫瘍学の成長分野をサポートします。特に治療に対する反応において、腫瘍の変異を長期にわたってモニターする能力は、より個別化された適応的ながん治療を可能にし、患者の転帰を改善します。

感染症診断では、HRMは病原体の突然変異、特に薬剤耐性という文脈での突然変異を検出する上で極めて重要な役割を果たしています。たとえば、HRMは、抗生物質、抗ウイルス剤、抗真菌剤に対する耐性をもたらす細菌、ウイルス、真菌の遺伝子変異の検出に使用できます。このような薬剤耐性の迅速な検出は、特に耐性が治療の失敗につながるような場合に、適切な治療方針を決定する上で極めて重要です。HRMは、抗生物質耐性の結核菌株、HIV薬剤耐性、インフルエンザの亜種に関連する変異の検出に使用されており、治療法についてタイムリーかつ十分な情報に基づいた決定を可能にしています。

HRMは農業バイオテクノロジーにおいても有用であり、遺伝子マーカー解析や植物育種プログラムに利用されています。作物の品種改良では、HRMにより、研究者はこれらの形質に関連する遺伝的変異を同定することで、耐病性、耐乾燥性、高収量性などの望ましい形質をスクリーニングすることができます。HRMはマーカー支援選抜において特に有用であり、育種家が有利な遺伝形質を持つ植物を迅速に同定し、改良作物品種の開発を加速するのに役立ちます。さらに、HRMは遺伝子組み換え作物（GMO）の検出にも利用されており、遺伝子組み換えに関連する特定のDNA配列を特定することで、作物が規制基準や安全基準を満たすことを確実にします。

エピジェネティクスの分野では、DNAメチル化パターンが遺伝子発現や疾病にどのように影響するかを理解する上で、HRMは極めて重要です。DNAメチル化の変化は、がん、自己免疫疾患、神経疾患など、さまざまな疾患と関連しています。HRMはメチル化パターンを迅速かつ効率的に解析できるため、疾患の進行や治療に対する反応におけるエピジェネティックな変化を研究するための重要なツールとなります。たとえばがん研究では、HRMはがん抑制遺伝子の過剰メチル化を検出するために使用されます。これは、通常は制御不能な細胞増殖を防ぐ遺伝子のサイレンシングにつながる可能性があります。

HRMは、遺伝的変異について大規模集団を迅速にスクリーニングできるため、集団遺伝学や疫学研究において貴重なツールとなります。SNPやその他の遺伝マーカーを集団全体にわたって同定することによって、研究者は病気の遺伝的基盤の理解を深め、遺伝的形質の広がりを追跡し、あるいは病原体の進化をモニターすることができます。HRMのハイスループット能力と比較的安価なコストは、データ解析と解釈に遺伝的変異の迅速な同定が必要な大規模遺伝学的研究に特に適しています。

高分解能融解分析市場の成長を促進する要因は何か？

高分解能融解（HRM）分析市場の成長は、迅速で費用対効果の高い遺伝子検査に対する需要の増加、精密医療に対するニーズの高まり、分子診断学の進歩、疾患研究におけるゲノミクスの役割の拡大など、いくつかの重要な要因によってもたらされます。主な促進要因の一つは、ヘルスケアにおける遺伝子検査需要の高まりであり、HRMは遺伝子変異、SNP、エピジェネティックな変化を同定するための迅速かつ正確な方法を提供します。遺伝子検査が日常的なヘルスケア、特にがん診断、新生児スクリーニング、出生前検査に組み込まれるようになるにつれて、HRMは臨床医や研究所にとって拡張可能で手頃なソリューションを提供します。

個別化医療への世界のシフトもHRM市場の主な促進要因です。特に腫瘍学において、患者の遺伝子構成に合わせた治療法が増えるにつれ、遺伝子変異を迅速かつ正確に検出できるツールの必要性が高まっています。HRMは、臨床医が治療方針の決定に役立つ実用的な変異を迅速に同定し、治療反応をモニターし、薬剤耐性の出現を追跡することを可能にするため、この需要を満たすのに適した位置にあります。遺伝子データをリアルタイムで迅速に解析できるHRMは、タイムリーな介入が患者の転帰に不可欠な個別化ヘルスケアに不可欠なツールです。

PCR装置、色素、および分析ソフトウェアの技術的進歩は、HRMの有用性をさらに高め、小規模の検査室や診療所を含む幅広いユーザーにとって、より利用しやすいものとなっています。より高感度なインターカレート色素、より優れたサーマルサイクラー、改良されたデータ解析ソフトウェアの開発により、HRMの精度と分解能が向上し、シーケンシングのような高価で手間のかかる技術に対抗できるようになった。このような技術革新により、HRMは臨床診断から農業研究まで、幅広い用途で実用的な選択肢となり、さまざまな分野での採用が進んでいます。

複雑な疾患の理解における遺伝子およびエピジェネティック研究の重要性の高まりも、HRMの需要に拍車をかけています。がん、心血管疾患、神経疾患などの疾患の原因となる遺伝子変異、エピジェネティック修飾、遺伝子発現パターンの調査にHRMを利用する研究者が増えています。HRMは、多数のサンプルをスクリーニングするためのハイスループットでコスト効率の高い方法を提供するため、多数の遺伝子マーカーの分析を必要とする調査研究に最適です。ゲノミクスとエピジェネティクスの研究が拡大し続ける中、HRMは健康や疾病の根底にある分子メカニズムを解明するための貴重なツールであり続けるであろう。

病原体の検出や薬剤耐性のモニタリングにおけるHRMの利用が増加していることも、市場の成長を促す重要な要因です。世界の保健社会が抗生物質耐性、新興ウイルスの脅威、迅速な診断ツールの必要性といった課題に直面する中、HRMは病原体の進化や耐性に関連する変異を検出するための信頼性の高い効率的な手法を提供しています。薬剤耐性の原因となる遺伝子の変異を迅速に特定できるHRMの能力により、ヘルスケアプロバイダーは治療戦略についてより多くの情報に基づいた決定を下すことができ、耐性株の蔓延を抑え、患者の転帰を改善することができます。

最後に、次世代シークエンシング（NGS）のような複雑な技術に比べ、HRMは手頃な価格で使いやすいため、臨床および研究の両研究室にとって魅力的な選択肢となっています。HRMは、検体の前スクリーニングや他の遺伝子検査法で得られた結果の確認に費用対効果の高いソリューションを提供し、NGSや他の高スループット技術を補完する価値あるものとなっています。この手頃な価格と高感度・高精度が相まって、特に迅速なターンアラウンドとコスト管理が重要な場面で、世界中の検査室での採用が進んでいます。

分子診断学の進歩、個別化医療への需要の高まり、ヘルスケアにおける遺伝子およびエピジェネティック研究の役割の拡大により、高分解能融解分析市場は大きく成長する態勢にあります。ゲノミクスが医学に革命を起こし続ける中、HRMは遺伝的変異を迅速かつ正確に検出し、治療方針の決定を導き、疾患の分子基盤の研究を進めるために不可欠なツールであり続けると思われます。

調査対象企業の例（全12件）

  • Agilent Technologies, Inc.
  • Azura Genomics Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Canon Biomedical Inc.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Meridian Bioscience, Inc.
  • Premier Biosoft International
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP12402

Global High-Resolution Melting Analysis Market to Reach US$419.2 Million by 2030

The global market for High-Resolution Melting Analysis estimated at US$343.8 Million in the year 2023, is expected to reach US$419.2 Million by 2030, growing at a CAGR of 2.9% over the analysis period 2023-2030. Other Applications, one of the segments analyzed in the report, is expected to record a 1.4% CAGR and reach US$31.1 Million by the end of the analysis period. Growth in the Epigenetics Application segment is estimated at 1.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$92.5 Million While China is Forecast to Grow at 2.7% CAGR

The High-Resolution Melting Analysis market in the U.S. is estimated at US$92.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$67.1 Million by the year 2030 trailing a CAGR of 2.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 2.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global High-Resolution Melting Analysis Market - Key Trends and Drivers Summarized

Is High-Resolution Melting Analysis (HRM) the Key to Rapid and Accurate Genomic Profiling in Modern Molecular Diagnostics?

High-Resolution Melting (HRM) analysis is revolutionizing molecular diagnostics and genetic research, but why is this method so crucial in modern laboratories? HRM is a post-PCR (Polymerase Chain Reaction) analysis technique used to identify genetic variations, such as single nucleotide polymorphisms (SNPs), mutations, or methylation differences in DNA. By monitoring the precise melting behavior of double-stranded DNA as it dissociates into single strands, HRM provides a rapid, high-throughput method for detecting subtle changes in DNA sequences. It is widely used in medical diagnostics, genetic research, epigenetic studies, and pathogen detection, offering a cost-effective, accurate, and efficient alternative to more labor-intensive sequencing methods.

The appeal of HRM lies in its ability to provide detailed genomic information with minimal setup and cost. HRM is fast, scalable, and can be automated, making it ideal for applications where rapid results are essential, such as in clinical settings, cancer research, and agricultural biotechnology. HRM’s sensitivity in detecting even minor genetic variations makes it a powerful tool for identifying disease-causing mutations, monitoring drug resistance, and validating genetic markers. As genomic research and precision medicine continue to expand, HRM is playing an increasingly pivotal role in advancing molecular diagnostics and personalized healthcare.

How Has Technology Advanced High-Resolution Melting Analysis?

Technological advancements have significantly improved the sensitivity, accuracy, and efficiency of High-Resolution Melting analysis, making it a more accessible and powerful tool for genetic and diagnostic applications. One of the key advancements has been in the development of more precise real-time PCR machines equipped with high-resolution optics and temperature control. These machines can accurately measure the melting curves of DNA with high precision, allowing for the detection of even the most subtle differences in DNA sequences. Improvements in thermal cyclers have enabled finer control over temperature changes, which is critical for generating reproducible and high-resolution melting profiles that differentiate between closely related genetic variants.

The introduction of intercalating dyes specifically designed for HRM has also enhanced the accuracy and performance of the technique. Traditional fluorescent dyes, such as SYBR Green, used in DNA amplification had limitations in detecting minor sequence variations. Newer dyes, like LCGreen and EvaGreen, bind more selectively to double-stranded DNA and produce more consistent fluorescence signals, enabling better discrimination of melting temperature shifts associated with small genetic changes. These dyes improve the sensitivity of HRM, making it possible to detect heterozygous mutations, SNPs, and methylation differences with greater clarity.

Advances in software for HRM analysis have further optimized the interpretation of complex melting profiles. Modern HRM software is designed to analyze melting curves with greater precision, allowing researchers to detect and quantify small genetic differences by comparing experimental data against known reference curves. These algorithms can automatically analyze multiple melting curves simultaneously, identify patterns, and even provide real-time feedback during an experiment. The integration of machine learning and AI-driven analysis tools has enhanced the ability of HRM to identify subtle variations in genetic data, improving the reliability of results and making the technique more user-friendly for both clinical and research applications.

Multiplexing capabilities have also improved the utility of HRM by enabling the simultaneous analysis of multiple genetic loci or samples in a single reaction. With the help of optimized primer design and dye selection, HRM can now be used to differentiate between multiple targets in a single run, increasing throughput and reducing costs. This advancement is particularly valuable in clinical diagnostics, where rapid detection of multiple mutations or genetic markers in a patient sample is critical for diagnosing diseases, monitoring treatment responses, or identifying drug-resistant pathogens. Multiplexed HRM also improves efficiency in genetic screening programs, where large populations can be analyzed for specific genetic variations in a time- and cost-efficient manner.

The growing integration of HRM with next-generation sequencing (NGS) technologies has expanded its role in genomics research. While HRM offers a rapid and cost-effective screening tool, it is increasingly used in conjunction with NGS to confirm or pre-screen samples before sequencing. HRM can quickly identify samples with known mutations or variations, reducing the need for extensive sequencing of entire genomes. This approach streamlines the genetic analysis process, saving time and resources in both research and clinical applications. HRM is particularly useful in large-scale genetic studies, where researchers need to quickly identify candidate samples for more in-depth sequencing.

Moreover, HRM has seen improvements in its application for methylation analysis, which is crucial for epigenetic studies. DNA methylation plays a significant role in gene regulation and has been implicated in various diseases, including cancer. Methylation-sensitive HRM (MS-HRM) allows researchers to differentiate between methylated and unmethylated DNA regions by exploiting differences in melting behavior, providing a rapid, non-sequencing-based method for epigenetic analysis. This makes HRM an essential tool for understanding the role of epigenetic modifications in gene expression and disease development, particularly in oncology.

Why Is High-Resolution Melting Analysis Critical for Modern Molecular Diagnostics and Research?

High-Resolution Melting analysis is critical for modern molecular diagnostics and research because it offers a rapid, accurate, and cost-effective method for detecting genetic variations, which are often the key to understanding diseases, drug resistance, and genetic disorders. In clinical diagnostics, HRM is used to identify mutations in genes associated with inherited diseases, such as cystic fibrosis, sickle cell anemia, and thalassemia. Its ability to detect single nucleotide polymorphisms (SNPs) and other minor genetic changes makes it ideal for screening patients for disease-causing mutations or identifying carriers of genetic disorders. This is particularly important in prenatal and newborn screening, where early detection of genetic abnormalities can guide medical interventions and improve patient outcomes.

HRM’s importance extends to cancer diagnostics and personalized medicine, where identifying specific mutations in cancer-related genes, such as BRCA1, KRAS, or EGFR, is crucial for determining the most effective treatment strategy. HRM is capable of rapidly detecting both known and novel mutations that can influence cancer progression or a patient’s response to targeted therapies. By enabling the quick identification of actionable mutations, HRM supports the growing field of precision oncology, where treatments are tailored to the genetic profile of an individual’s tumor. The ability to monitor tumor mutations over time, particularly in response to treatment, allows for more personalized and adaptive cancer care, improving outcomes for patients.

In infectious disease diagnostics, HRM plays a pivotal role in detecting pathogen mutations, particularly in the context of drug resistance. For example, HRM can be used to detect mutations in the genes of bacteria, viruses, or fungi that confer resistance to antibiotics, antivirals, or antifungal agents. This rapid detection of drug resistance is crucial in guiding appropriate treatment decisions, particularly in cases where resistance can lead to treatment failure. HRM has been used to detect mutations associated with antibiotic-resistant tuberculosis strains, HIV drug resistance, and influenza variants, enabling timely and informed decisions on treatment options.

HRM is also valuable in agricultural biotechnology, where it is used for genetic marker analysis and plant breeding programs. In crop improvement, HRM allows researchers to screen for desirable traits, such as disease resistance, drought tolerance, or higher yield potential, by identifying genetic variations linked to these traits. HRM is particularly useful in marker-assisted selection, where it helps breeders quickly identify plants with favorable genetic traits, accelerating the development of improved crop varieties. In addition, HRM is used to detect genetically modified organisms (GMOs) by identifying specific DNA sequences associated with genetic modifications, ensuring that crops meet regulatory and safety standards.

In the field of epigenetics, HRM is critical for understanding how DNA methylation patterns influence gene expression and disease. Changes in DNA methylation are associated with various diseases, including cancer, autoimmune disorders, and neurological conditions. HRM provides a rapid and efficient method for analyzing methylation patterns, making it an important tool for studying epigenetic changes in disease progression and response to therapy. In cancer research, for example, HRM is used to detect hypermethylation of tumor suppressor genes, which can lead to the silencing of genes that normally prevent uncontrolled cell growth.

The ability of HRM to quickly screen large populations for genetic variations makes it a valuable tool in population genetics and epidemiological studies. By identifying SNPs or other genetic markers across populations, researchers can better understand the genetic basis of diseases, track the spread of genetic traits, or monitor the evolution of pathogens. HRM’s high-throughput capability and relatively low cost make it particularly well-suited for large-scale genetic studies, where the rapid identification of genetic variations is necessary for data analysis and interpretation.

What Factors Are Driving the Growth of the High-Resolution Melting Analysis Market?

The growth of the High-Resolution Melting (HRM) analysis market is driven by several key factors, including the increasing demand for rapid and cost-effective genetic testing, the growing need for precision medicine, advancements in molecular diagnostics, and the expanding role of genomics in disease research. One of the primary drivers is the rising demand for genetic testing in healthcare, where HRM provides a fast and accurate method for identifying genetic mutations, SNPs, and epigenetic changes. As genetic testing becomes more integrated into routine healthcare, particularly in cancer diagnostics, newborn screening, and prenatal testing, HRM offers a scalable and affordable solution for clinicians and laboratories.

The global shift toward personalized medicine is also a major driver of the HRM market. As more therapies, especially in oncology, are tailored to the genetic makeup of patients, the need for tools that can rapidly and accurately detect genetic mutations is increasing. HRM is well-positioned to meet this demand because it allows clinicians to quickly identify actionable mutations that inform treatment decisions, monitor treatment response, and track the emergence of drug resistance. The ability to rapidly analyze genetic data in real time makes HRM an essential tool in personalized healthcare, where timely intervention is critical for patient outcomes.

Technological advancements in PCR instruments, dyes, and analytical software have further enhanced the utility of HRM, making it more accessible to a broader range of users, including smaller laboratories and clinics. The development of more sensitive intercalating dyes, better thermal cyclers, and improved data analysis software has increased the accuracy and resolution of HRM, allowing it to compete with more expensive and labor-intensive techniques like sequencing. These innovations have made HRM a practical choice for a wide range of applications, from clinical diagnostics to agricultural research, driving its adoption across multiple sectors.

The growing importance of genetic and epigenetic research in understanding complex diseases is also fueling the demand for HRM. Researchers are increasingly using HRM to study genetic variations, epigenetic modifications, and gene expression patterns that contribute to diseases such as cancer, cardiovascular conditions, and neurological disorders. HRM provides a high-throughput, cost-effective method for screening large numbers of samples, making it ideal for research studies that require the analysis of many genetic markers. As research in genomics and epigenetics continues to expand, HRM will remain a valuable tool for uncovering the molecular mechanisms underlying health and disease.

The increasing use of HRM in pathogen detection and monitoring drug resistance is another key factor driving market growth. As the global health community faces challenges such as antibiotic resistance, emerging viral threats, and the need for rapid diagnostic tools, HRM offers a reliable and efficient method for detecting mutations associated with pathogen evolution and resistance. HRM’s ability to quickly identify mutations in genes responsible for drug resistance enables healthcare providers to make more informed decisions about treatment strategies, reducing the spread of resistant strains and improving patient outcomes.

Lastly, the affordability and ease of use of HRM compared to more complex techniques like next-generation sequencing (NGS) have made it an attractive option for both clinical and research laboratories. HRM offers a cost-effective solution for pre-screening samples or confirming results obtained from other genetic testing methods, making it a valuable complement to NGS and other high-throughput technologies. This affordability, combined with its high sensitivity and accuracy, is driving its adoption in laboratories worldwide, particularly in settings where rapid turnaround and cost control are critical.

With advancements in molecular diagnostics, the growing demand for personalized medicine, and the expanding role of genetic and epigenetic research in healthcare, the High-Resolution Melting analysis market is poised for significant growth. As genomics continues to revolutionize medical science, HRM will remain an essential tool for quickly and accurately detecting genetic variations, guiding treatment decisions, and advancing research into the molecular basis of disease.

Select Competitors (Total 12 Featured) -

  • Agilent Technologies, Inc.
  • Azura Genomics Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Canon Biomedical Inc.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Meridian Bioscience, Inc.
  • Premier Biosoft International
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • High-Resolution Melting Analysis - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growth in Oncology and Genetic Testing Expands Addressable Market for High-Resolution Melting Analysis
    • Role of High-Resolution Melting Analysis in Enhancing Genotyping Accuracy and Speed Strengthens Business Case
    • Growth in Use of HRM Analysis in Infectious Disease Diagnostics Expands Market Opportunities
    • Expansion of High-Resolution Melting Analysis in Pharmacogenomics Drives Market Growth
    • Role of HRM in Supporting Clinical Trials and Drug Development Expands Addressable Market
    • Increasing Focus on Non-invasive Prenatal Testing (NIPT) Expands Adoption of High-Resolution Melting Analysis
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World High-Resolution Melting Analysis Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for High-Resolution Melting Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for High-Resolution Melting Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for SNP Genotyping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for SNP Genotyping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for SNP Genotyping by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Mutation Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Mutation Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Mutation Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Species Identification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Species Identification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Species Identification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Pathogen Identification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Pathogen Identification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Pathogen Identification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Epigenetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • High-Resolution Melting Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • JAPAN
    • High-Resolution Melting Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • CHINA
    • High-Resolution Melting Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • EUROPE
    • High-Resolution Melting Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for High-Resolution Melting Analysis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for High-Resolution Melting Analysis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • FRANCE
    • High-Resolution Melting Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • GERMANY
    • High-Resolution Melting Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • High-Resolution Melting Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • High-Resolution Melting Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of World 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of World 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030

IV. COMPETITION